CSCI
Price:
$2.72
Market Cap:
$6.51M
COSCIENS Biopharma Inc. is a specialized biopharmaceutical company dedicated to the global development and commercialization of innovative therapeutic and diagnostic products. Its operations extend across Canada, Switzerland, Ireland, Denmark, Germany, the United States, and other international territories. The company's flagship product is Macrilen (macimorelin), an orally administered peptidomimetic ghrelin receptor (GHSR-1a) agonist. This compound works by stimulating growth hormone secretion through its interaction with the GHSR-1a receptor, primarily serving for the diagnosis of both adult and childhood-onset growth hormone deficiency. It also shows promise in other endocrinology and on...[Read more]
Industry
Biotechnology
IPO Date
1996-07-18
Stock Exchange
NASDAQ
Ticker
CSCI
According to COSCIENS Biopharma Inc.’s latest financial reports and current stock price. The company's current ROE is -13.16%. This represents a change of 86.61% compared to the average of -7.05% of the last 4 quarters.
The mean historical ROE of COSCIENS Biopharma Inc. over the last ten years is 32.58%. The current -13.16% ROE has changed -140.38% with respect to the historical average. Over the past ten years (40 quarters), CSCI's ROE was at its highest in in the September 2017 quarter at 492.63%. The ROE was at its lowest in in the June 2020 quarter at -370.57%.
Average
32.58%
Median
7.02%
Minimum
-401.79%
Maximum
603.52%
Discovering the peaks and valleys of COSCIENS Biopharma Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 102.85%
Maximum Annual ROE = 603.52%
Minimum Annual Increase = -386.35%
Minimum Annual ROE = -401.79%
| Year | ROE | Change |
|---|---|---|
| 2023 | -19.51% | -315.41% |
| 2022 | 9.06% | 81.83% |
| 2021 | 4.98% | -54.79% |
| 2020 | 11.02% | -95.51% |
| 2019 | 245.31% | 11.73% |
| 2018 | 219.56% | -63.62% |
| 2017 | 603.52% | -250.21% |
| 2016 | -401.79% | 73.20% |
| 2015 | -231.98% | 102.85% |
| 2014 | -114.36% | -386.35% |
The current ROE of COSCIENS Biopharma Inc. (CSCI) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-1.82%
5-year avg
50.17%
10-year avg
32.58%
COSCIENS Biopharma Inc.’s ROE is less than Biora Therapeutics, Inc. (121.86%), greater than Turnstone Biologics Corp. (-136.68%), greater than CervoMed Inc. (-136.08%), greater than Channel Therapeutics Corporation (-164.11%), greater than Tvardi Therapeutics, Inc. (-64.17%), greater than Omega Therapeutics, Inc. (-118.82%), greater than TNF Pharmaceuticals, Inc. (-59.95%), less than Apexigen, Inc. (48.27%), greater than IMV Inc. (-495.17%), less than Kineta, Inc. (26.26%),
| Company | ROE | Market cap |
|---|---|---|
| 121.86% | $994.99K | |
| -136.68% | $8.21M | |
| -136.08% | $22.68M | |
| -164.11% | $8.90M | |
| -64.17% | $24.77M | |
| -118.82% | $7.90M | |
| -59.95% | $9.18M | |
| 48.27% | $9.57M | |
| -495.17% | $23.42K | |
| 26.26% | $7.05M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like COSCIENS Biopharma Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like COSCIENS Biopharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is COSCIENS Biopharma Inc.'s ROE?
How is the ROE calculated for COSCIENS Biopharma Inc. (CSCI)?
What is the highest ROE for COSCIENS Biopharma Inc. (CSCI)?
What is the 3-year average ROE for COSCIENS Biopharma Inc. (CSCI)?
What is the 5-year average ROE for COSCIENS Biopharma Inc. (CSCI)?
How does the current ROE for COSCIENS Biopharma Inc. (CSCI) compare to its historical average?